Pfizer/BioNTech may not win FDA renewal for pediatric COVID shot: report

13 hours ago 1
FDA headquarters in Washington DC.

JHVEPhoto

The U.S. Food and Drug Administration (FDA) is unlikely to renew the authorization granted to use Pfizer (NYSE:PFE) and BioNTech’s (BNTX) COVID-19 vaccine in young children this fall, The Guardian reported on Tuesday, citing an email sent by a

Recommended For You

More Trending News

Read Entire Article